GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Global Corp (ASX:AVR) » Definitions » Enterprise Value

Anteris Technologies Global (ASX:AVR) Enterprise Value : A$344.64 Mil (As of Jan. 18, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Global Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Anteris Technologies Global's Enterprise Value is A$344.64 Mil. Anteris Technologies Global's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was A$-91.94 Mil. Therefore, Anteris Technologies Global's EV-to-EBIT ratio for today is -3.75.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Anteris Technologies Global's Enterprise Value is A$344.64 Mil. Anteris Technologies Global's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-88.63 Mil. Therefore, Anteris Technologies Global's EV-to-EBITDA ratio for today is -3.89.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Anteris Technologies Global's Enterprise Value is A$344.64 Mil. Anteris Technologies Global's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was A$3.89 Mil. Therefore, Anteris Technologies Global's EV-to-Revenue ratio for today is 88.64.


Anteris Technologies Global Enterprise Value Historical Data

The historical data trend for Anteris Technologies Global's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Global Enterprise Value Chart

Anteris Technologies Global Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.73 22.78 128.20 296.22 312.82

Anteris Technologies Global Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 368.92 296.22 314.90 312.82 342.91

Competitive Comparison of Anteris Technologies Global's Enterprise Value

For the Medical Devices subindustry, Anteris Technologies Global's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Enterprise Value falls into.



Anteris Technologies Global Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Anteris Technologies Global's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Anteris Technologies Global's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies Global  (ASX:AVR) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Anteris Technologies Global's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=344.638/-91.94
=-3.75

Anteris Technologies Global's current Enterprise Value is A$344.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies Global's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was A$-91.94 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Anteris Technologies Global's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=344.638/-88.625
=-3.89

Anteris Technologies Global's current Enterprise Value is A$344.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies Global's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-88.63 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Anteris Technologies Global's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=344.638/3.888
=88.64

Anteris Technologies Global's current Enterprise Value is A$344.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies Global's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was A$3.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies Global Enterprise Value Related Terms

Thank you for viewing the detailed overview of Anteris Technologies Global's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies Global Business Description

Traded in Other Exchanges
Address
9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. It is also engaged in research and development of ComASUR, a delivery system that allows accurate valve placement, and the manufacturing and selling of proprietary ADAPT regenerative tissue products. The company generates a majority of its revenue from the United States and the rest from Switzerland and Australia.

Anteris Technologies Global Headlines

From GuruFocus